GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » YoY EPS Growth

Japan Tissue Engineering Co (TSE:7774) YoY EPS Growth : -100.00% (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Japan Tissue Engineering Co's YoY EPS Growth for the quarter that ended in Sep. 2024 was -100.00%.

Japan Tissue Engineering Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was 円0.00.


Japan Tissue Engineering Co YoY EPS Growth Historical Data

The historical data trend for Japan Tissue Engineering Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co YoY EPS Growth Chart

Japan Tissue Engineering Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.89 -62.52 -6.70 -46.49 119.65

Japan Tissue Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.15 83.33 79.46 289.78 -100.00

Japan Tissue Engineering Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Japan Tissue Engineering Co's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(3.53--17.96)/ | -17.96 |
=119.65 %

Japan Tissue Engineering Co's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(0-0.34)/ | 0.34 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Tissue Engineering Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines